TYLER, Texas, April 11, 2007 (PRIME NEWSWIRE) -- Biogenerics Limited (Other OTC:BIGN) Board of Directors is pleased to provide its shareholders with the following company update.
James Lancaster, CEO, is pleased to report that, "All previously announced transactions are proceeding and updates on these will be placed on the Company's web site and announced in detail in future press releases."
The WW Oil and Gas Inc. dividend shares have been issued by the Transfer Agency and, in some cases, have already been received by shareholders. Shares that have to clear the Deposit Transfer Corporation to be further credited to brokerage firms may take up to 90 days to complete. Shareholders will receive 1 (one) WW Oil and Gas Inc. common restricted share for every 19 (nineteen) Biogenerics Ltd. shares held as of the January 2, 2007 record date.
Biogenerics is actively continuing its finalization of the Winfield Oil Field transaction. Mr. Lancaster stated, "This transaction is proceeding nicely within the time frame as indicated by the Company's previous press release."
Website: http:/www.bignltd.com
About Biogenerics Limited
Biogenerics is a diversified investment venture capital firm focused on exploiting and distributing domestic oil and gas reserves. Biogenerics also has joint venture activities with Tyche Energy Inc and Hydroslotter Corp.
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this release that are forward-looking statements are based on current expectations and assumptions that are subject to known and unknown risks, uncertainties, or other factors which may cause actual results, performance, or achievements of the company to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Actual results could differ materially because of factors such as the effect of general economic and market conditions, entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, technological shifts, and delays in product development and related product release schedules, any of which may cause revenues and income to fall short of anticipated levels. All information in this release is as of the date of this release. The company undertakes no duty to update any forward-looking statement to conform the statement to actual results or changes in the company's expectations.